Intended for healthcare professionals

CCBY Open access
Research

Mirtazapine added to SSRIs or SNRIs for treatment resistant depression in primary care: phase III randomised placebo controlled trial (MIR)

BMJ 2018; 363 doi: https://doi.org/10.1136/bmj.k4218 (Published 31 October 2018) Cite this as: BMJ 2018;363:k4218